LJMU conducted cutting-edge sports and exercise science research
GlaxoSmithKline are a science-led healthcare company. GlaxoSmithKline research and develop vaccines, medicines and consumer healthcare products.
Research was carried out on behalf of GlaxoSmithKline by a team in LJMU's School of Sport and Exercise Sciences. As part of the project, an investigation was conducted. The investigation informed the preparation of players in a variety of invasive team sports that predominantly use intermittent training programmes, such as soccer, rugby, hockey and basketball.
Aims of the investigation
Evaluate the effects of initial muscle glycogen concentration on the physiological adaptations to chronic intermittent exercise
- Evaluate the influence of exogenous carbohydrate supplementation on the physiological adaptations to chronic intermittent exercise programmes performed with both high and low initial muscle glycogen concentrations
LJMU's School of Sport and Exercise Sciences worked with GlaxoSmithKline on this project.
LJMU staff involved with the project include:
- Barry Drust
- Tom Reilly
- Don MacLaren
- James Morton
- GlaxoSmithKline accessed LJMU's first-rate facilities within the School of Sport and Exercise Sciences
- The organisation utilised the expertise of Dr Barry Drust
- The project informs the use and development of GlaxoSmithKline’s commercial product lines, which are relevant to sport and exercise
Academic and student benefits
- Strengthened LJMU's links with GlaxoSmithKline
- Reinforced LJMU’s reputation as a leading authority in the applied intermittent exercise physiology field
- Provided scientific information to support academic programmes within the School of Sport and Exercise Sciences
- Enabled the development of new analytical techniques for the laboratories located within the School of Sport and Exercise Sciences
- Provided opportunities for developing future research programmes for new and existing staff within the School